资讯

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
GSK has received approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab).
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven ...
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
Eli Lilly and Company has received marketing authorisation from the Australian Therapeutic Goods Administration (TGA) for ...
At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.
The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...
The Trump administration’s budget reconciliation bill has passed the US House of Representatives by a wafer-thin single-vote ...
Viz.ai is to enter a multi-year collaboration with Sanofi and Regeneron aimed at deploying and assessing an AI-powered ...